Table 5:
HIV RNA viral load in HIV-positive men and women in a rural and periurban community in KwaZulu-Natal, South Africa, 2014–15
| Women (N=2955)a |
Men (N=1014)a |
|
|---|---|---|
| Overall HIV RNA viral load | ||
| Median, IQRb | 67 (<20–13816) | 4940 (<20–45448) |
| Geometric mean copies per mL,(range) c | 163 (<20–5400000) | 811 (<20–2300000) |
| Viral suppressione (n/N, percentage, (95% CI) | 1574/2955 54·8 (52·0–57·5) | 401/1014 41·9 (37·1–46·7) |
| On antiretroviral therapyd | ||
| Median (copies per mL, IQR)b | <20 (<20–<20) | <20 (<20–36) |
| Geometric mean copies per mL, (range) c | <20 (<20–1000000) | <20 (<20–516440) |
| Viral suppressione (n/N, percentage, (95% CI) | 1086/1251 87·2 (84·6–89·8) | 284/341 83·9 (78·5–89·3) |
| Not on antiretroviral therapyd | ||
| Median (copies per mL, IQR)b | 8177 (179–30808) | 27042 (3434–76519) |
| Geometric mean copies per mL, (range) c | 1966 (<20–5400000) | 8084 (<20–2300000) |
| Viral suppressione (n/N, percentage, (95% CI) | 488/1704 27·4 (24·3–30·5) | 117/673 17·5 (13·5–21·6) |
a
Plasma viral load data are missing for nine women and four men
b
To calculate the geometric mean and median HIV RNA viral load, HIV-positive participants with undetectable viral load or <20 copies per mL were assigned a value of 1 or 10 copies per mL respectively and reported as <20 copies per mL (ie, the lower limit of quantification for the assay).
e
Viral suppression at viral load <400 copies per mL
d
Self-report. Percentages are population-weighted.